RIPK1 and acute myeloid leukemia: Furthermore, the differentiation of AML cells could be increased by decreasing RIP1 alone, which supporting the hypothesis that the abnormal expression and dysfunction of RIP1 may be pro- or anti-oncogenic, depending on the genetic background of the cells and microenvironment of the tumor.